Repositorio Dspace

Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement

Mostrar el registro sencillo del ítem

dc.contributor.author Español, Ignacio
dc.contributor.author Romera, Marta
dc.contributor.author Gutiérrez-Meca, María-Dolores
dc.contributor.author García, María-del-Carmen
dc.contributor.author Tejedor, Aurelia
dc.contributor.author Martínez, Antonio
dc.contributor.author Ibáñez, Jerónima
dc.contributor.author de-Arriba-de-la-Fuente, Felipe
dc.contributor.author Minguela-Puras, Alfredo
dc.contributor.author Iturbe-Hernández, Teodoro
dc.contributor.author López, María-Dolores
dc.date.accessioned 2026-02-12T12:14:03Z
dc.date.available 2026-02-12T12:14:03Z
dc.date.issued 2017-08
dc.identifier.citation Español I, Romera M, Gutiérrez-Meca MD, García MDC, Tejedor A, Martínez A, et al. Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement. Clinical Case Reports. agosto de 2017;5(8):1258-60.
dc.identifier.issn 2050-0904
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/24377
dc.description.abstract The dismal outcome of pleuropericardial extramedullary multiple myeloma (EMM) reflects both the selection of resistant disease and absence of useful drugs. Carfilzomib and dexamethasone should be explored in advanced EMM patients, even for bortezomib-resistant patients, as may provide much longer overall survival than previously reported treatments.
dc.language.iso eng
dc.publisher WILEY
dc.rights Attribution 4.0 International
dc.rights.uri http://creativecommons.org/licenses/by/4.0 *
dc.title Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 28781837
dc.relation.publisherversion https://onlinelibrary.wiley.com/doi/10.1002/ccr3.1015
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1002/ccr3.1015
dc.journal.title Clinical Case Reports


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta